Parallel metabolic pathway engineering for aerobic 1,2‐propanediol production in Escherichia coli
Biotechnology Journal · 2024-08 · 19 (8)
DOI: 10.1002/biot.202400210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 21.08.2024. Verfasst von Daisuke Nonaka und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, Nada-ku, Kobe, Hyogo, Japan. Hauptthemen laut MEDLINE: Escherichia coli, Metabolic Engineering, Glucose, Metabolic Networks and Pathways. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: JSPS Research Fellow, Transformative Research Areas, Precursory Research for Embryonic Science and Technology (PRESTO).
Abstract (Originalsprache)
The demand for the essential commodity chemical 1,2‐propanediol (1,2‐PDO) is on the rise, as its microbial production has emerged as a promising method for a sustainable chemical supply. However, the reliance of 1,2‐PDO production in Escherichia coli on anaerobic conditions, as enhancing cell growth to augment precursor availability remains a substantial challenge. This study presents glucose‐based aerobic production of 1,2‐PDO, with xylose utilization facilitating cell growth. An engineered strain was constructed capable of exclusively producing 1,2‐PDO from glucose while utilizing xylose to support cell growth. This was accomplished by deleting the gloA , eno , eda , sdaA , sdaB , and tdcG genes for 1,2‐PDO production from glucose and introducing the Weimberg pathway for cell growth using xylose. Enhanced 1,2‐PDO production was achieved via yagF overexpression and disruption of the ghrA gene involved in the 1,2‐PDO‐competing pathway. The resultant strain, PD72, produced 2.48 ± 0.15 g L −1 1,2‐PDO with a 0.27 ± 0.02 g g −1 ‐glucose yield after 72 h cultivation. Overall, this study demonstrates aerobic 1,2‐PDO synthesis through the isolation of the 1,2‐PDO synthetic pathway from the tricarboxylic acid cycle.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University, Nada-ku, Kobe, Hyogo, Japan.
- Center for Sustainable Resource Science, Tsurumi-ku, Yokohama, Japan.
- Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Hyogo, Japan.
- PRESTO, Japan Science and Technology Agency (JST), Kawaguchi, Saitama, Japan.
ORCID-Profile: Akihiko Kondo, Tsutomu Tanaka
Förderung
- JSPS Research Fellow
- Transformative Research Areas
- Precursory Research for Embryonic Science and Technology (PRESTO)
- Scientific Research
- Japan Science and Technology Corporation
Zitieren
APA
Nonaka, D., Hirata, Y., Kishida, M., Mori, A., Fujiwara, R., Kondo, A., Mori, Y., Noda, S., & Tanaka, T. (2024). Parallel metabolic pathway engineering for aerobic 1,2‐propanediol production in Escherichia coli. Biotechnology Journal, 19(8). https://doi.org/10.1002/biot.202400210
Vancouver
Nonaka D, Hirata Y, Kishida M, Mori A, Fujiwara R, Kondo A, et al. Parallel metabolic pathway engineering for aerobic 1,2‐propanediol production in Escherichia coli. Biotechnology Journal. 2024;19(8). doi:10.1002/biot.202400210
BibTeX
@article{Nonaka2024,
author = {Nonaka, Daisuke and Hirata, Yuuki and Kishida, Mayumi and Mori, Ayana and Fujiwara, Ryosuke and Kondo, Akihiko and Mori, Yutaro and Noda, Shuhei and Tanaka, Tsutomu},
title = {Parallel metabolic pathway engineering for aerobic 1,2‐propanediol production in Escherichia coli},
journal = {Biotechnology Journal},
year = {2024},
volume = {19},
number = {8},
doi = {10.1002/biot.202400210}
}
EUVIMED